| VAMYLIO Prothena Biosciences Limited
79392815 02 Feb 2024 | on 03 Dec 2024
| Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes Class 042 Class 042 Computer & Software Services & Scientific Services Licensing of intellectual property in the field of biotechnology Class 045 Personal & Legal & Social Services Research and development in the pharmaceutical and biotechnology fields | | | AMCLERUS Prothena Biosciences Limited
79393086 02 Feb 2024 | on 03 Dec 2024
| Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes Class 042 Class 042 Computer & Software Services & Scientific Services Licensing of intellectual property in the field of biotechnology Class 045 Personal & Legal & Social Services Research and development in the pharmaceutical and biotechnology fields | | | NEOTOPE BIOSCIENCES PROTHENA BIOSCIENCES LIMITED
85587795 03 Apr 2012 | on 09 Oct 2024
| Pharmaceutical and biopharmaceutical preparations for the treatment, m... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biopharmaceutical preparations for the treatment, management, prevention, diagnosis and prognosis of diseases, conditions and disorders associated with Alzheimers disease, amyloidosis, cancer, dementia, diabetes, inflammatory disease, and Parkinsons disease | | | NEOTOPE PROTHENA BIOSCIENCES LIMITED
85587787 03 Apr 2012 | on 08 Oct 2024
| Pharmaceutical and biopharmaceutical preparations for the treatment, m... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biopharmaceutical preparations for the treatment, management, prevention, diagnosis and prognosis of diseases, conditions and disorders associated with Alzheimers disease, amyloidosis, cancer, dementia, diabetes, inflammatory disease, and Parkinsons disease | | | ZALGAMI Prothena Biosciences Limited
87662284 27 Oct 2017 | on 24 May 2022
| Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis | | | AMLYCAS Prothena Biosciences Limited
87653874 20 Oct 2017 | on 24 May 2022
| Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes | | | AMLUCCA Prothena Biosciences Limited
87639411 10 Oct 2017 | on 24 May 2022
| Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes | | | AMYDERRO Prothena Biosciences Limited
87639430 10 Oct 2017 | on 24 May 2022
| Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes | | | BIRCLERZI Prothena Biosciences Limited
79403591 12 Jul 2024 | on 31 Dec 2024 | Biopharmaceuticals and pharmaceuticals for the prevention, treatment, ... Class 005 Class 005 Pharmaceutical Products Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes. Class 042 Class 042 Computer & Software Services & Scientific Services Licensing of intellectual property in the field of biotechnology. Class 045 Personal & Legal & Social Services Research and development in the pharmaceutical and biotechnology fields. | | | OTHAIR PROTHENA BIOSCIENCES LIMITED
97039262 22 Sep 2021 | on 09 Jun 2024 | Research and development in the pharmaceutical and biotechnology field... Class 042 Class 042 Computer & Software Services & Scientific Services The English translation of "OTHAIR" in the mark is "patients". | | 
